Congress Resource Centre    Global Edition Home Contact us		Up to the minute coverage from key international congresses Offering the latest congress news in oncology ! DG Dispatch your speedy delivery of the latest news and highlights direct from medical congresses ... keeping you medically current !  DG Dispatches - Oncology 12/16/2009 Ketorolac Tromethamine Does Not Reduce Pain, Discomfort Associated With Mammograms: Presented at SABCS 12/15/2009 Anthracycline-Docetaxel Chemo as Effective, but Less Toxic Than Anthracycline Polychemotherapy for Breast Cancer: Presented at SABCS 12/15/2009 Zoledronic Acid Improves Bone Loss Associated With Adjuvant AI Therapy in Postmenopausal Breast Cancer Patients: Presented at SABCS 12/15/2009 Benefits of Docetaxel After FEC Regimen Sustained for 8 Years in Node-Positive Breast Cancer: Presented at SABCS 12/15/2009 Letrozole/Trastuzumab Superior to Letrozole Alone for Patients With Both HR+, HER2+ Metastatic Breast Cancer: Presented at SABCS 12/14/2009 Exemestane Therapy Show Unfavourable Changes in Lipid Profile: Presented at SABCS 12/14/2009 Bevacizumab Plus Docetaxel Improves Progression-Free Survival, but Not Overall Survival in Metastatic Breast Cancer: Presented at SABCS 12/14/2009 Adding Bevacizumab to Second-Line Chemo Improves Progression-Free Survival in Metastatic Breast Cancer: Presented at SABCS 12/14/2009 Switching to an Aromatase Inhibitor at Year 5 of Tamoxifen Therapy Reduces Breast Cancer Recurrence: Presented at SABCS 12/14/2009 Primary Tumour Resection Improves Outcomes in Advanced Breast Cancer: Presented at SABCS 12/13/2009 ACE Inhibitors and ARBs May Protect Against Breast Cancer Recurrence: Presented at SABCS 12/13/2009 Neratinib/Paclitaxel Combination Shows Promise in Metastatic Breast Cancer: Presented at SABCS 12/13/2009 Long-Term Follow-Up Using PET-CT Can Help Detect Lymph Node Recurrence in Breast Cancer: Presented at SABCS 12/13/2009 Adjuvant Trastuzumab With Chemotherapy for 1 Year Delays Breast Cancer Progression: Presented at SABCS 12/12/2009 Whole Radiation Recommended for Mucinous Carcinoma: Presented at SABCS 12/12/2009 Docetaxel Plus Capecitabine Shows More Benefit as First-Line Therapy for Metastatic Breast Cancer Than Docetaxel Plus Epirubicin: Presented at SABCS 12/12/2009 No Survival Benefit for 5-FU/Docetaxel After Preoperative Epirubicin/Cyclophosphamide in Inflammatory Breast Cancer: Presented at SABCS 12/12/2009 Adding Bevacizumab to Second-Line Chemo Improves Progression-Free Survival in Metastatic Breast Cancer: Presented at SABCS 12/12/2009 Risks of Autologous Stem-Cell Transplantation Outweigh Benefits in Treating High-Risk Breast Cancer: Presented at SABCS 12/12/2009 Adding Lapatinib, Continuing Trastuzumab Despite Progression Adds Months to Breast Cancer Survival: Presented at SABCS 12/11/2009 Ibandronate Offers Pain Relief With Renal Safety in Women With Breast Cancer, Metastatic Bone Disease: Presented at SABCS 12/11/2009 Exemestane for 5 Years Not Superior to Tamoxifen Followed by Exemestane for Breast Cancer: Presented at SABCS 12/11/2009 No Cardiac Safety Problems When Casopitant Is Given With Anthracycline for Malignant Solid Tumours: Presented at SABCS 12/11/2009 High-Dose Fulvestrant Postpones Disease Progression in Advanced Breast Cancer: Presented at SABCS 12/11/2009 Lymphedema Continues to Appear Years After Breast Cancer Treatment: Presented at SABCS 12/11/2009 Pregnancy Does Not Worsen Outcomes Among Women With Breast Cancer: Presented at SABCS 12/11/2009 Optimal Duration of Neoadjuvant Letrozole Longer Than the Traditional 4 Months to Permit Breast-Conserving Surgery: Presented at SABCS 12/11/2009 Letrozole Superior to Tamoxifen in Hormone Receptor-Positive Early Breast Cancer: Presented at SABCS 12/11/2009 Febrile Neutropenia Occurs More Frequently in Real World Setting Than in Clinical Trials: Presented at SABCS 12/11/2009 Lapatinib Plus Nab-Paclitaxel Shows Promise for HER2-Positive Breast Cancer: Presented at SABCS All contents Copyright (c) 2002 P\S\L Consulting Group Inc. All rights reserved.